Brusa Gianluca, Zuffa Elisa, Mancini Manuela, Benvenuti Michela, Calonghi Natalia, Barbieri Enza, Santucci Maria Alessandra
Istituto di Ematologia e Oncologia Medica Lorenzo e Ariosto Seràgnoli, Universita di Bologna, Bologna, Italy.
Br J Haematol. 2006 Feb;132(3):359-69. doi: 10.1111/j.1365-2141.2005.05873.x.
The BCR-ABL fusion gene, originating from the balanced (9;22) translocation, is the molecular hallmark and the causative event of chronic myeloid leukaemia (CML). The interactions of its p210 protein constitutively activated and improperly confined to the cytoplasm with multiple regulatory signals of cell cycle progression, apoptosis and self-renewal, induce the illegitimate enlargement of clonal haematopoiesis and genetic instability that drives its progression towards the fully transformed phenotype of blast crisis. However, its effects on the basic transcription machinery and chromatin remodelling are unknown. Our study underscored histone H4 hyperacetylation associated with p210 tyrosine kinase in vitro and in vivo and its role in BCR-ABL transcription. Histone H4 hyperacetylation proceeds, at least partly, from the 'loss of function' of histone deacetylase 1 protein, a critical component of Rb-mediated transcriptional repression, in consequence of its cytoplasmatic compartmentalisation.
源自平衡易位(9;22)的BCR-ABL融合基因是慢性髓性白血病(CML)的分子标志和致病因素。其组成型激活且异常局限于细胞质的p210蛋白与细胞周期进程、细胞凋亡和自我更新的多种调节信号相互作用,诱导克隆性造血的异常扩大和基因不稳定,从而推动其向急变期的完全转化表型发展。然而,其对基本转录机制和染色质重塑的影响尚不清楚。我们的研究强调了体外和体内与p210酪氨酸激酶相关的组蛋白H4高乙酰化及其在BCR-ABL转录中的作用。组蛋白H4高乙酰化至少部分源于组蛋白去乙酰化酶1蛋白(Rb介导的转录抑制的关键成分)因其细胞质区室化而出现的“功能丧失”。